跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gentraxone - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gentraxone
Approved
STANDARD
Gentraxone
Yeluri Formulations Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7e84ba714435764a
Company
Yeluri Formulations Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
7e84ba714435764a
Drug Approval Philippines Name
Gentraxone
Product Name
Gentraxone
Registration Number
DRP-10960-01
Brand Name
Gentraxone
Generic Name
Ceftriaxone (as Sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1 g
Manufacturer
Yeluri Formulations Pvt. Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
GA2 Pharmaceutical Inc.
Issuance Date
25 October 2022
Expiry Date
22 December 2026
Pharmacologic Category
Antibacterial (Third Generation Cephalosorin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7e84ba714435764a
Type
Standard
Back to Philippines FDA Approvals